-adenant
Drugs that block adenosine receptors.
- Drugs ending in -adenant: 9
- Approved somewhere: 0
- With a US drug page: 0
- Stem
- -adenant
- Class
- Drugs that block adenosine receptors
Approved and clinical-stage drugs in ChEMBL whose names ending in -adenant, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Preladenant | Phase 3 | ADORA2A | Adenosine A2a receptor antagonist |
| Tozadenant | Phase 3 | ADORA2A | Adenosine A2a receptor antagonist |
| Etrumadenant | Phase 2 | ADORA2A, ADORA2B | Adenosine A2a receptor antagonist |
| Imaradenant | Phase 2 | ADORA2A | Adenosine A2a receptor antagonist |
| Muvadenant | Phase 2 | — | — |
| Sipagladenant | Phase 2 | ADORA2A | Adenosine A2a receptor inverse agonist |
| Vipadenant | Phase 2 | ADORA2A | Adenosine A2a receptor antagonist |
| Ciforadenant | Phase 1 | ADORA2A | Adenosine A2a receptor antagonist |
| Inupadenant | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO